Security key
30050B101
Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH)
CUSIP: 30050B101
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Class A Common Stock, par value $0.01 per share
- Shares outstanding
- 112,318,617
- Total 13F shares
- 135,659,696
- Share change
- +4,590,522
- Total reported value
- $1,147,817,881
- Put/Call ratio
- 54%
- Price per share
- $8.46
- Number of holders
- 237
- Value change
- +$12,305,118
- Number of buys
- 120
- Number of sells
- 112
Report period
Q3 2025
Institutions
237
Top holders
10
EVH full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Evolent Health, Inc. SEC filings
Evolent Health, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 30050B101
Recent filing periods:
Top shareholders of EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| CADIAN CAPITAL MANAGEMENT, LP |
13F
13D/G
|
Company |
9.3%
from 13D/G
|
10,424,701
|
$117,382,133 | — | 30 Jun 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
— |
3.1%
|
3,577,197
|
$35,199,618 | $0 | 31 Dec 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13D/G
13F
|
Company |
0.4%
|
442,802
|
$5,016,947 | -$113,228,542 | 30 Jun 2025 | |
| John Paul Johnson |
3/4/5
|
Chief Financial Officer |
0.28%
|
309,245
|
$2,576,010 | — | 01 Jul 2025 | |
| Peter J. Grua |
3/4/5
|
Director |
0.07%
|
82,647
|
$766,137 | — | 05 Jun 2025 | |
| Cheryl Scott |
3/4/5
|
Director |
0.07%
|
73,476
|
$681,122 | — | 05 Jun 2025 | |
| Richard M. Jelinek |
3/4/5
|
Director |
0.06%
|
66,437
|
$615,870 | — | 05 Jun 2025 | |
| Kim Keck |
3/4/5
|
Director |
0.05%
|
61,501
|
$570,114 | — | 05 Jun 2025 | |
| Craig A. Barbarosh |
3/4/5
|
Director |
0.05%
|
53,935
|
$499,977 | — | 05 Jun 2025 | |
| Russell Monroe Glass |
3/4/5
|
Director |
0.04%
|
42,297
|
$392,092 | — | 05 Jun 2025 | |
| Toyin Ajayi |
3/4/5
|
Director |
0.03%
|
34,074
|
$315,865 | — | 05 Jun 2025 | |
| Shawn M. Guertin |
3/4/5
|
Director |
0.02%
|
21,979
|
$203,745 | — | 05 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.7%
|
10,921,531
|
$122,976,439 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
8.3%
|
9,376,620
|
$105,580,741 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
7.2%
|
8,052,587
|
$90,672,143 | — | 30 Jun 2025 | |
| Durable Capital Partners LP |
13F
|
Company |
5.7%
|
6,423,293
|
$72,326,279 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
5.7%
|
6,420,384
|
$72,293,524 | — | 30 Jun 2025 | |
| Engaged Capital LLC |
13F
|
Company |
5.2%
|
5,854,468
|
$65,921,310 | — | 30 Jun 2025 | |
| Rubicon Founders LLC |
13F
|
Company |
5.2%
|
5,816,123
|
$65,489,545 | — | 30 Jun 2025 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
3.9%
|
4,324,883
|
$48,698,183 | — | 30 Jun 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
3.6%
|
4,086,852
|
$46,014,343 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.8%
|
3,102,354
|
$34,932,506 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.8%
|
3,094,598
|
$34,845,174 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.6%
|
2,972,952
|
$33,475,440 | — | 30 Jun 2025 | |
| 8 KNOTS MANAGEMENT, LLC |
13F
|
Company |
2.6%
|
2,913,135
|
$32,801,900 | — | 30 Jun 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
2.5%
|
2,820,700
|
$31,761,082 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
2.5%
|
2,811,749
|
$31,660,294 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.5%
|
2,774,318
|
$31,238,383 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
2,667,642
|
$30,040,905 | — | 30 Jun 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.9%
|
2,104,373
|
$23,695,240 | — | 30 Jun 2025 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
1.7%
|
1,920,200
|
$21,621,452 | — | 30 Jun 2025 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
1.6%
|
1,780,854
|
$20,052,416 | — | 30 Jun 2025 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
1.2%
|
1,392,524
|
$15,679,820 | — | 30 Jun 2025 | |
| Sea Cliff Partners Management, LP |
13F
|
Company |
1.1%
|
1,233,828
|
$13,892,903 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.1%
|
1,182,816
|
$13,318,508 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1%
|
1,162,797
|
$13,093,092 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1%
|
1,125,690
|
$12,675,270 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
1%
|
1,125,105
|
$12,668,682 | — | 30 Jun 2025 | |
| Glenmede Investment Management, LP |
13F
|
Company |
0.96%
|
1,078,313
|
$12,141,804 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.94%
|
1,058,797
|
$11,922,054 | — | 30 Jun 2025 | |
| Camber Capital Management LP |
13F
|
Company |
0.76%
|
850,000
|
$9,571,000 | — | 30 Jun 2025 | |
| Rock Point Advisors, LLC |
13F
|
Company |
0.76%
|
849,960
|
$9,570,550 | — | 30 Jun 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.68%
|
760,211
|
$8,559,976 | — | 30 Jun 2025 | |
| First Light Asset Management, LLC |
13F
|
Company |
0.66%
|
738,550
|
$8,316,073 | — | 30 Jun 2025 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.63%
|
703,038
|
$7,916,208 | — | 30 Jun 2025 | |
| GABELLI FUNDS LLC |
13F
|
Company |
0.62%
|
698,800
|
$7,868,488 | — | 30 Jun 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.6%
|
671,554
|
$7,561,698 | — | 30 Jun 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.59%
|
663,010
|
$7,465,493 | — | 30 Jun 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.58%
|
647,761
|
$7,293,789 | — | 30 Jun 2025 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.57%
|
638,357
|
$7,187,000 | — | 30 Jun 2025 |
Institutional Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q3 2025
As of 30 Sep 2025,
Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) was held by
237 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
135,659,696 shares.
The largest 10 holders included
CADIAN CAPITAL MANAGEMENT, LP, VANGUARD GROUP INC, BlackRock, Inc., FMR LLC, MORGAN STANLEY, EVENTIDE ASSET MANAGEMENT, LLC, Rubicon Founders LLC, Engaged Capital LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, and JPMORGAN CHASE & CO.
This page lists
238
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
218
Q3 2025 holders
237
Holder diff
19
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.